US Patent 6919483 Immunomodulation with novel pharmaceutical compositions
Patent 6919483 was granted and assigned to MediQuest Therapeutics on July, 2005 by the United States Patent and Trademark Office.
All edits
Edits on 22 Oct, 2023
Golden AI
Edits made to:
Infobox (+14 properties)
Article (+628 characters)
Article
Patent abstract
The synthesis and use of a novel class of tumor necrosis factor (TNFα) inhibitors and immunomodulators are provided. These compounds have pharmacological applications as well as uses in assays relating to TNFα and other involved cytokines. As pharmaceuticals, these compounds are used to treat inflammatory, infectious, autoimmune or other proliferative diseases and conditions related to the unwanted presence or activity of TNFα and/or one or more other involved cytokines, alone or in combination with other agents. Examples of compounds of the present invention are those having the structures as shown below:
Infobox
Is a
Patent Applicant
0
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Arthur Yeung0
Bruce H. Devens0
Kevin J. Kennedy0
Maralee McVean0
Mark R. Burns0
Date of Patent
July 19, 2005
0Patent Application Number
104437430
Date Filed
May 23, 2003
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 6919483 Immunomodulation with novel pharmaceutical compositions
Find more entities like US Patent 6919483 Immunomodulation with novel pharmaceutical compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.